Viewing Study NCT04187560


Ignite Creation Date: 2025-12-25 @ 2:01 AM
Ignite Modification Date: 2025-12-26 @ 12:48 AM
Study NCT ID: NCT04187560
Status: COMPLETED
Last Update Posted: 2020-12-10
First Post: 2019-11-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
Sponsor: LB Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module